BVS: Rega marang dodolan Bioventus Inc
Is it worth investing in Bioventus Inc. (BVS) amid recovering profitability and the expansion of biologics? This chart on GURU.Markets shows that the company's price-to-sales ratio has stabilized at 1.30. Proven orthobionic systems provide stable income, while the systematic update of the R&D pipeline in tissue regeneration ensures sustainable business growth without volatile swings.
Rincian analitis perusahaan Bioventus Corp (BVS)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Bioventus Inc.|BVS - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Bioventus Global|BVS - Utang perusahaan|Rasio utang marang kapitalisasi buku Bioventus Corp|BVS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Bioventus|Likuiditas darurat bioventus.com
- indikator pendapatan resik lan kelipatan nilai:
BVS - Bathi resik perusahaan|Proyeksi bathi resik Bioventus Inc.|BVS - Koefisien rega marang bathi|Pangali Forward P/E Bioventus Inc|BVS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Bioventus Corp|BVS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Bioventus|BVS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bioventus.com|BVS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Bioventus Inc.
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:bioventus.com BVS
To minimize long-term risks, it is critical for investors to correlate market capitalization with actual sales volume, which is clearly demonstrated by the price-to-sales ratio. The stability of this metric for Bioventus Inc. (BVS) is supported by cost optimization through regulated production outsourcing, where the ratio of business value to revenue reflects a premium for operational efficiency and the absence of dependence on specific component suppliers.
Karo sapa Bioventus Inc. saingan
Kapitalisasi marang pendapatan bostonscientific.com BSX|Multiplikator P/S EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Rega marang dodolan|OmniPod - Multiplikator P/S|ZBH (Zimmer Biomet Holdings) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|ALGN - Koefisien rega marang pendapatan|GMED (Globus Medical) - Multiplikator P/S|Kapitalisasi marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator P/S ATEC|Multiplikator P/S Artivion Corp (AORT)|Rasio rega marang pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang pendapatan|ESTA: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator P/S|Rega marang dodolan Embecta Health (EMBC)|Rasio rega marang pendapatan Tandem Diabetes Care|AXGN - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan SIBN (SI-BONE)|Multiplikator P/S Orthofix Medical (OFIX)|Multiplikator P/S KIDS (OrthoPediatrics)|Koefisien rega marang pendapatan Treace Corp (TMCI)|SRTA - Rasio rega marang pendapatan|Rasio rega marang dodolan CARL|RxSight (RXST) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ClearPoint Neuro|STXS (Stereotaxis Corp) - Multiplikator P/S|Rega marang dodolan Neuronetics, Inc STIM|Rasio rega marang pendapatan Sight Sciences, Inc. (SGHT)|orchestrabiomed.com - Rasio kapitalisasi marang pendapatan|Anika Therapeutics, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NSPR (InspireMD Inc)|Jin Medical International Ltd - Multiplikator P/S|VANI: Rasio rega marang pendapatan|XTNT: Multiplikator P/S|NMTC - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Modular Medical Inc|Rega marang dodolan Myomo Inc. MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Rasio rega marang pendapatan VVOS (Vivos Therapeutics Inc)|Multiplikator P/S NVNO (enVVeno Medical)|Sintx Technologies Inc (SINT) - Rega marang dodolan|TNON - Rasio rega marang pendapatan|LFWD (ReWalk Robotics) - Rasio kapitalisasi marang pendapatan|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|IVF: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan BBLG|Multiplikator P/S axonics.com|Rasio rega marang pendapatan BIOLASE (BIOL)|Koefisien rega marang pendapatan dynatronics.com|Paragon 28 - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan INVO
